Seminis

St. Louis, United States Founded: 1994 • Age: 32 yrs Listed Acquired By Monsanto
Genetically modified seeds for fruits and vegetables are supplied worldwide.

About Seminis

Seminis is a Healthcare company based in St. Louis (United States) founded in 1994, and was acquired by Monsanto in January 2005. Genetically modified seeds for fruits and vegetables are supplied worldwide. It operates in the Healthcare and Agriculture sectors. Its chief executive, as recorded, is Alfonso Romo. Its focus areas include Food and Agriculture Tech, Crop Tech, Farm Inputs and Seeds. Its legal entity in India is Seminis Vegetable Seeds (India) Private Limited (U01110MH1992PTC065055). Its competitors include Benson Hill, Cibus and Pairwise; 3 of its 3 listed competitors have raised funding.

Company details

Seminis provides genetically modified seeds of fruits and vegetables across the world. Seminis patents every seed they develop with United States Patent and Trademark Office(USPTO) or obtain Plant Variety Protection(PVP) certificate from United States Department of Agriculture(USDA) to protect the crop variety it has developed. Seminis claims to have 3500 varieties of seeds across 20 crops such as Melons, Onions, Sweet peppers and watermelons.

Key Metrics

Investors in Seminis

Seminis has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Monsanto and Fox Paine and Company.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Fox Paine and Company is engaged in investment management services.
foxpaine.comMiami Beach, United States
Genetically modified seeds and biotechnology traits are developed for farmers.
1901monsanto.comSt. Louis, United States
Premium access

Investor details for Seminis

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Seminis Vegetable Seeds (India) Private Limited (Seminis)

Seminis Vegetable Seeds (India) Private Limited is the primary company behind Seminis. The board of Seminis Vegetable Seeds (India) Private Limited currently have 5 directors; the longest-serving is Lee Kyu Yon, appointed in 2001.

DirectorDesignationAppointedTenureEntity
Lee Kyu Yon
DIN 02054011
Director15 Feb 200125 yrs 8 moSeminis Vegetable Seeds (India) Private Limited
Chandra Pathak
DIN 00237019
Whole-time director23 Jan 200224 yrs 9 moSeminis Vegetable Seeds (India) Private Limited
Daniel Smith
DIN 00230112
Additional Director23 Jun 200620 yrs 4 moSeminis Vegetable Seeds (India) Private Limited
Hiroshi Okumura
DIN 00645394
Additional Director04 Sep 200620 yrs 1 moSeminis Vegetable Seeds (India) Private Limited
Ashok Kumar Sinha
DIN 02156959
Additional Director16 Feb 200818 yrs 8 moSeminis Vegetable Seeds (India) Private Limited

People of Seminis

1 people are tracked at Seminis (1 in leadership).

NameRoleGroup
Alfonso Romo
Chairman & CEOLeadership
Premium access

Complete people profiles for Seminis

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Seminis

4 dated milestones of Seminis across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded Seminis is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Exit Acquired by Fox Paine.
  4. Exit Acquired by Monsanto.

Competitors of Seminis

Seminis has 3 listed competitors in our database, 3 of them funded. They include Benson Hill, Cibus and Pairwise.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
bensonhill.com2012St. Louis, United States$406.99M151
Provider of plant-based food ingredients
cibus.com2001San Diego, United States$34.47M129
Gene editing solutions are provided for agriculture.
pairwise.com2017Durham, United States$155M
New crop varieties are developed using gene-editing for agrigenomics.
Premium access

Detailed competitors of Seminis

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Seminis

Websites that share an audience with Seminis (seminis.com).

Similar websites

Websites whose visitors overlap most with Seminis. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
genuity.com
100%
View details
newgmc.com
92%
#9,389,313View details
vetomag-arak.hu
vetomag-arak.hu
91%
–
horticeres.com.br
91%
#2,560,117View details
plantae.hu
plantae.hu
90%
#8,324,194–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 7 similar websites and full traffic analytics for Seminis

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 7 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as Seminis (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Seminis

Premium access

Complete news archive for Seminis

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seminis

Seminis was founded in 1994.

Seminis is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.

Alfonso Romo is the CEO of Seminis, as recorded in our data.

Seminis provides genetically modified seeds of fruits and vegetables across the world. Seminis patents every seed they develop with United States Patent and Trademark Office(USPTO) or obtain Plant Variety Protection(PVP) certificate from United States Department of Agriculture(USDA) to protect the crop variety it has developed. Seminis claims to have 3500 varieties of seeds across 20 crops such as Melons, Onions, Sweet peppers and watermelons.

Seminis's top competitors include Benson Hill, Cibus and Pairwise.

Seminis has 2 investors. Key investors include Monsanto, and Fox Paine and Company.

Seminis operates through Seminis Vegetable Seeds (India) Private Limited.

Yes. Seminis was acquired by Monsanto in January 2005.

The legal entities of Seminis currently have 6 directors, including Chandra Pathak, Daniel Smith, Hiroshi Okumura and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available